NO924098L - Tiadiazinonderivater, fremgangsmaate for fremstilling derav, samt farmasoeytiske preparater som inneholder minst ett av derivatene - Google Patents

Tiadiazinonderivater, fremgangsmaate for fremstilling derav, samt farmasoeytiske preparater som inneholder minst ett av derivatene

Info

Publication number
NO924098L
NO924098L NO92924098A NO924098A NO924098L NO 924098 L NO924098 L NO 924098L NO 92924098 A NO92924098 A NO 92924098A NO 924098 A NO924098 A NO 924098A NO 924098 L NO924098 L NO 924098L
Authority
NO
Norway
Prior art keywords
derivatives
tiadiazino
procedures
preparing
pharmaceutical preparations
Prior art date
Application number
NO92924098A
Other languages
English (en)
Other versions
NO303013B1 (no
NO924098D0 (no
Inventor
Rochus Jonas
Michael Klockow
Joachim Leibrock
Hans-Jochen Schliep
Christoph Seyfried
Michael Wolf
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO924098D0 publication Critical patent/NO924098D0/no
Publication of NO924098L publication Critical patent/NO924098L/no
Publication of NO303013B1 publication Critical patent/NO303013B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO924098A 1991-10-23 1992-10-22 Tiadiazinonderivater, farmas÷ytiske preparater som inneholder minst ett av derivatene, samt anvendelse av derivater til fremstilling av legemidler NO303013B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4134893A DE4134893A1 (de) 1991-10-23 1991-10-23 Thiadiazinone

Publications (3)

Publication Number Publication Date
NO924098D0 NO924098D0 (no) 1992-10-22
NO924098L true NO924098L (no) 1993-04-26
NO303013B1 NO303013B1 (no) 1998-05-18

Family

ID=6443196

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924098A NO303013B1 (no) 1991-10-23 1992-10-22 Tiadiazinonderivater, farmas÷ytiske preparater som inneholder minst ett av derivatene, samt anvendelse av derivater til fremstilling av legemidler

Country Status (16)

Country Link
US (1) US5276027A (no)
EP (1) EP0539806B1 (no)
JP (1) JP3193789B2 (no)
AT (1) ATE116644T1 (no)
AU (1) AU653444B2 (no)
CA (1) CA2081049A1 (no)
CZ (1) CZ281377B6 (no)
DE (2) DE4134893A1 (no)
DK (1) DK0539806T3 (no)
ES (1) ES2066540T3 (no)
HU (1) HU214337B (no)
MX (1) MX9206042A (no)
NO (1) NO303013B1 (no)
PL (1) PL171273B1 (no)
TW (1) TW309518B (no)
ZA (1) ZA928236B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW309520B (no) * 1994-04-26 1997-07-01 Mitsubishi Chem Corp
DE19500558A1 (de) * 1995-01-11 1996-07-18 Merck Patent Gmbh 3-Alkoxycarbonyl-thiadiazinone
DE19502699A1 (de) * 1995-01-28 1996-08-01 Merck Patent Gmbh Arylalkyl-thiadiazinone
DE19533975A1 (de) * 1995-09-14 1997-03-20 Merck Patent Gmbh Arylalkyl-diazinone
DE10150517A1 (de) * 2001-10-12 2003-04-17 Merck Patent Gmbh Verwendung von Phosphodiesterase IV-Inhibitoren
MXPA04003668A (es) * 2001-10-31 2004-07-22 Merck Patent Gmbh Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
EP1716133B1 (en) 2004-02-04 2008-03-26 Nycomed GmbH 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors
CN101602687A (zh) * 2008-06-13 2009-12-16 上海特化医药科技有限公司 6-硝基苯乙酮类化合物、其制备方法及用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495185A (en) * 1981-11-12 1985-01-22 Imperial Chemical Industries, Plc 1,2,4-Triazin-3(2H) ones
AU614965B2 (en) * 1987-06-06 1991-09-19 Merck Patent Gesellschaft Mit Beschrankter Haftung Thiadiazinones
ATE180475T1 (de) * 1990-09-21 1999-06-15 Rohm & Haas Dihydropyridazinone und pyridazinone als fungizide

Also Published As

Publication number Publication date
PL171273B1 (pl) 1997-03-28
DE59201148D1 (de) 1995-02-16
HU214337B (hu) 1998-03-02
US5276027A (en) 1994-01-04
EP0539806B1 (de) 1995-01-04
CA2081049A1 (en) 1993-04-24
CZ281377B6 (cs) 1996-09-11
ATE116644T1 (de) 1995-01-15
DK0539806T3 (da) 1995-03-13
HU9203332D0 (en) 1992-12-28
CZ263692A3 (en) 1993-05-12
JPH05222017A (ja) 1993-08-31
TW309518B (no) 1997-07-01
ZA928236B (en) 1993-05-06
NO303013B1 (no) 1998-05-18
ES2066540T3 (es) 1995-03-01
MX9206042A (es) 1993-04-01
NO924098D0 (no) 1992-10-22
AU2723192A (en) 1993-04-29
DE4134893A1 (de) 1993-04-29
PL296314A2 (en) 1993-05-04
JP3193789B2 (ja) 2001-07-30
EP0539806A1 (de) 1993-05-05
AU653444B2 (en) 1994-09-29
HUT67938A (en) 1995-05-29

Similar Documents

Publication Publication Date Title
NO306464B1 (no) Benzimidazolforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene for fremstilling av medikamenter
RU93056837A (ru) Гексагидронафталиновые сложноэфирные производные, способы их получения и фармацевтическая композиция
DE3677452D1 (de) Chinazolinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
NO924098D0 (no) Tiadiazinonderivater, fremgangsmaate for fremstilling derav, samt farmasoeytiske preparater som inneholder minst ett av derivatene
FI924370A0 (fi) Karbamatderivat av 4-amino-3 -isoxazolidinoner, 3-amino-1-hydroxipyrrolidin-2-oner och 1-amino-1 -cyklopropankarboxylsyraanaloger, foerfarande foer framstaellning av dessa och anvaendning av dessa som laekemedel.
DK1022276T3 (da) Epoxysuccinamidderivater
ATE114154T1 (de) Thienotriazolodiazepine und ihre pharmazeutische verwendung.
KR940003953A (ko) 1. 4-벤조디옥산 유도체
DK624989A (da) Makrolidforbindelser
DK0447116T3 (da) Urinstof-derivater, deres fremstilling samt lægemidler indeholdende sådanne derivater
DK283984D0 (da) Benzodiazepinderivater og fremgangsmaade til fremstilling deraf
DE3862791D1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
RU94002313A (ru) Эфирные производные гексагидронафталина, их получение и фармацевтическая композиция на их основе
NO167286C (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzotiazepin-derivater.
DE69110217D1 (de) Derivate der Kaffeinsäure und sie enthaltende pharmazeutische Zusammensetzungen.
ATE37368T1 (de) Benzothiazolon-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
NO159271C (no) Analogifremgangsmaate for fremstiling av terapeutisk aktive substituerte isokinolinderivater.
ATE144900T1 (de) Verwendung von xanthinderivaten gegen magengeschwüre
PT91438A (pt) Processo para a preparacao de novas 2-amino 4-morfolino-6-profil-1,3,5- -triazinas e dos seus sais
NO169899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiadiazolguanidiner
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
DK460789D0 (da) 2-aminoacetamidderivater